Simple Summary The treatment of hepatocellular carcinoma is burdened by an
unacceptable recurrence rate after loco-regional treatment. Unlike all other solid tumors, no …

Introduction A proteomic analysis of hepatocellular carcinoma (HCC) has revealed that Heat
Shock Protein 70 (HSP70) is among the cancer antigen proteins of HCC. Moreover, we …

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. This
malignancy is associated with poor prognosis and high mortality. Novel approaches for …

Background: CxC motif chemokine ligands (CXCLs) are critical regulators of cancer
immunity and angiogenesis, which affect disease progression and treatment responses. The …

Hepatocellular carcinoma (HCC) is the most common primary liver cancer with dismal
prognosis when diagnosed at advanced stages. Surgical resection of the primary tumor or …

Simple Summary The prognostic evaluation and therapeutic management of
hepatocarcinoma (HCC) is based on the Barcelona Liver Cancer Clinic (BCLC). In the past …

Immune-oncology based regimens have shown efficacy in advanced hepatocellular
carcinoma and have been implemented as standard of care as first line therapy. Their …

Background Hepatocellular carcinoma (HCC) is common, but remains difficult to treat.
Natural killer (NK) cells are cells of the innate immune system that have potent anti-cancer …

Hepatocellular carcinoma (HCC) has long been a major global clinical problem as one of
the most common malignant tumours with a high rate of recurrence and mortality. Although …

Cytokine-induced killer (CIK) cell immunotherapy represents an effective treatment strategy
for treating hepatocellular carcinoma (HCC). However, the therapeutic benefits of CIK cell …